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BNip3 localizes to the outer mitochondrial membrane, where it functions in mitophagy andmitochondrial dynamics. While the
BNip3 protein is constitutively expressed in adult liver from fedmice, we have shown that its expression is superinduced by fast-
ing of mice, consistent with a role in responses to nutrient deprivation. Loss of BNip3 resulted in increased lipid synthesis in the
liver that was associated with elevated ATP levels, reduced AMP-regulated kinase (AMPK) activity, and increased expression of
lipogenic enzymes. Conversely, there was reduced -oxidation of fatty acids in BNip3 null liver and also defective glucose output
under fasting conditions. These metabolic defects in BNip3 null liver were linked to increased mitochondrial mass and increased
hepatocellular respiration in the presence of glucose. However, despite elevated mitochondrial mass, an increased proportion of
mitochondria exhibited loss of mitochondrial membrane potential, abnormal structure, and reduced oxygen consumption. Ele-
vated reactive oxygen species, inflammation, and features of steatohepatitis were also observed in the livers of BNip3 null mice.
These results identify a role for BNip3 in limiting mitochondrial mass andmaintaining mitochondrial integrity in the liver that
has consequences for lipid metabolism and disease.
Modulation of mitochondrial mass is emerging as a majoradaptive response to changes in energy balance arising from
deficiencies in oxygen or glucose availability, among other nutri-
ent stresses. For example, nutrient-sensitive changes in PGC-1
activity alter expression of genes required for mitochondrial bio-
genesis, in addition to genes required for fatty acid metabolism
(17, 38).While mitochondrial biogenesis increases mitochondrial
mass, this is countered by the role of mitophagy in targeting dys-
functional mitochondria for degradation at the autophagosome,
resulting in reduced mitochondrial mass (28, 29, 70). Defects in
autophagy have been linked to liver cancer (25, 44, 65) and have
also been shown to promote hepatic insulin resistance (19, 67).
However, this cannot be attributed to defective mitochondrial
function, since autophagy-deficient liver also exhibits increased
endoplasmic reticulum (ER) stress (67), protein aggregation (31),
and defective lipidophagy (59). To date, a specific role for mi-
tophagy in preventing hepatic steatosis or other liver pathologies
has not been identified.
Hypoxia modulates mitochondrial mass through both de-
creasingmitochondrial biogenesis (74) and increasingmitophagy
(3, 64, 73). These effects aremediated by hypoxia-inducible factor
(HIF) transcription factors, acting on the one hand to inhibit
Myc-induced expression of PGC-1 (74) and on the other to in-
duce expression of themitochondrial proteins BNIP3 andNIX (3,
4, 64, 73). Initial functional characterization of BNIP3 and NIX
indicated that these proteins were loosely conserved members of
the BH3-only subgroup of the Bcl-2 family of cell death regulators
(7, 8, 52, 68), and indeed, evidence from ischemia-reperfusion
injury experiments in cardiomyocytes supports a prodeath func-
tion for both BNip3 and Nix (15, 22, 60), although this likely
requires a second signal, such as acidosis or calcium release from
the endoplasmic reticulum (9, 16, 34, 75).
A role for BNIP3 and NIX in promoting cell death in response
to specific stresses has been offset by evidence that overexpression
of BNIP3 is not sufficient to kill cells (49, 64) but rather promotes
mitochondrial fragmentation and mitophagy through interac-
tions with OPA-1 and LC-3, respectively (35, 53). Similarly, NIX
plays a key role in the maturation of red blood cells through de-
velopmentally regulated induction of mitophagy (55, 57) that in-
volves interactions with the LC3-related molecule GABARAP
(56). Thus, BNIP3 and NIX appear to play dual roles in both
mitophagy and cell death, although how the cell switches between
these different functions is not clear.
In the present study, we found that BNip3 is expressed atmark-
edly higher levels in adult mouse liver than in most other tissues
examined and was further induced to very high levels in liver by
overnight fasting. Given the importance of mitochondrial func-
tion in metabolism and evidence that hypoxia regulates both mi-
tophagy and metabolic processes (32, 42, 51), we were thus inter-
ested in examining the consequences of BNip3 loss for cellular and
systemicmetabolism.We have shown for the first time that BNip3
is required to prevent excess lipid accumulation in the liver and to
promote hepatic glucose output in response to fasting and that
loss of BNip3 leads to steatohepatitis. These defects were linked to
both increased mitochondrial mass and increased mitochondrial
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dysfunction, demonstrating the importance of proper control of
mitophagy for normal liver metabolism and for prevention of
liver disease.
MATERIALS AND METHODS
Mice. Wild-type, BNip3 heterozygous, and BNip3 null mice were main-
tained on a pure C57B/6 genetic background. Male mice were used for all
analyses and were generally used with age-matched control littermates
between the ages of 3 and 5 months of age unless otherwise stated. Mice
were fasted for 24 h for experiments unless stated otherwise. All mice were
housed in a barrier facility, fed normal chow, and kept on a 12-h-light/12-
h-dark cycle. Conditionally targeted Hif-1/, Hif-2/, and Arnt/
mice were generated as reported previously (20).
In vivometabolic assays and measurements. Three- to five-month-
old male mice were fasted for 16 h for a glucose tolerance test (GTT),
glucagon stimulation test (GST), pyruvate challenge (PC), or alanine
challenge (AC), while a 4-h fast was used for the insulin tolerance tests
(ITT). The GTT was performed by intraperitoneal (i.p.) injection of 2 g
D-glucose/kg body weight, ITT was conducted using 20 U insulin/kg, PC
was done by injection of 1.5 g/kg sodium pyruvate, AC was carried out by
injection of 1.0 g/kg alanine, and GST was conducted using 20 mg/kg of
glucagon (Sigma). Glucose measurements were made using a Freestyle
Lite glucometer, and serum insulin was measured by enzyme-linked im-
munosorbent assay (ELISA) (Alpco).
Primary hepatocyte culture, in vitro assays, and cell staining. Pri-
mary hepatocytes were obtained by collagenase perfusion of live mice as
described previously (71) with the following modifications: type IV colla-
genase (100 U/ml; Worthington Biochemical) was used for digestion, the
flow rate was 9 ml/min, medium used for isolation and plating was Dul-
becco’s modified Eagle medium (DMEM) with 25 mM glucose and 10%
fetal bovine serum (FBS), and viability as determined by trypan blue stain-
ing was90% for all preparations. Cells were plated on collagen-coated
(8g/cm2) plates. Cells weremaintained overnight in serum-free DMEM
containing 5 to 25 mM glucose, and all cells were used within 30 h of
plating. Total intracellular glycogen was assessed by a modification of the
methods outlined in reference 39.Gluconeogenesis was evaluated bymea-
surement of glucose released into the medium via the 2,2=-azinobis(3-
ethylbenzthiazolinesulfonic acid (ABTS)-linked glucose oxidase-peroxi-
dase method. Medium was changed to glucose-free phenol red-free
DMEM (Mediatech) containing 10 mM lactate or glycerol; forskolin (25
M), if used, was added at the start of the assay. Beta oxidation of [9,10-
3H]-palmitic acid (Perkin Elmer) was assessed based upon amodification
of the method outlined previously (45). Sodium palmitate (200 M) was
coupled to bovine serumalbumin (BSA) in a 3-to-1molar ratio. Carnitine
(1 mM) was added at the start of the assay, while etomoxir (10 M) was
preincubated for 30 min prior to the start of the assay. Lipogenesis from
glucose was determined by measuring the incorporation of [U-14C]glu-
cose (American Radiolabeled Chemicals) into the lipid-extractable frac-
tion of cell lysates. Cells were lysed in H2O, scraped into scintillation vials
containing organic scintillation fluid (Betafluor; National Diagnostics),
and vigorously shaken. Radioactivity in the organic fraction was quanti-
fied using a scintillation counter. Fluorescence microscopy of live or
methanol-fixed primary hepatocytes was performed using boron-dipyr-
romethene (BODIPY) (Invitrogen), 1 mM tetramethylrhodamine, ethyl
ester (TMRE) (Invitrogen), and anti-heat shock protein 60 (anti-HSP60)
antibodies (Stressgen) and analyzed on Zeiss Axiovert 200Mmicroscope.
Western blot analyses. Snap-frozen tissues were pulverized and ex-
tracted in an equal volume of either RIPA extraction buffer (1% sodium
deoxycholate, 0.1% SDS, 1%Triton X-100, 10mMTris-HCl, pH 8.0, and
0.14MNaCl) or NP-40 lysis buffer (150 mMNaCl, 50 mMTris-HCl, pH
7.5, 0.5% NP-40, and 5 mM -mercaptoethanol) for Western blotting.
Primary antibodies to BNip3 (Sigma, Cell Signaling), Acly, malic enzyme,
-tubulin (all from Abcam), Cox IV (Mitosciences), HSP60, cytochrome
c, AMP-regulated kinase (AMPK), phosphorylated AMPK (p-AMPK),
Acc, Fasn, Raptor, p-Raptor (all Cell Signaling), and LC-3B (Novus) were
used with appropriate secondary antibodies prior to detection carried out
by enhanced chemiluminescence (ECL film; GE Healthcare). All blots
were performed at least three times.
Transmission electronmicroscopy. Small pieces of liver were fixed in
2.5% gluteraldehyde, and sections were analyzed using a Philips CM120
transmission electron microscope.
Quantitative PCR. Total genomic DNA was isolated from adult liver
using standard approaches. Relative mitochondrial-to-nuclear genome
ratios were determined using TaqMan real-time PCR primers specific to
mitochondrial genome-encoded NADH dehydrogenase subunit 1 (Nd1)
and cytochrome b (cytb) and to nuclear genome encoded -globin. Total
RNA was extracted from whole liver using TRIzol reagent (Invitrogen).
cDNA synthesis from total RNA was performed using the High Capacity
RNA-to-cDNA master mix (Applied Biosystems). mRNA levels were
quantified by real-time PCR using TaqMan primers, and all samples were
analyzed in triplicate. Relative quantification of RNA amounts was deter-
mined using the comparative threshold cycle (CT) method. Relative
amounts of mRNA for genes analyzed were normalized to endogenous
control -actin and expressed relative to wild-type amounts (reference
sample). Relative levels of mouse FBP1, Pepck, and Pklr were determined
using specific TaqMan real-time PCR primers.
Immunohistochemistry and tissue staining. Tissues were frozen in
O.C.T. compound (TissueTEK) for sectioning and staining for oil red O
or dihydroethidine (catalog no. D23107; Sigma). Alternatively, tissues
were fixed in 10% neutral buffered formalin embedded in paraffin, and
sections were stained with periodic acid-Schiff (PAS) stain, terminal de-
oxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
(TUNEL), and other immunohistochemical stains, using citrate buffer
and heat denaturation of the epitope, as described previously (41). Liver
sections were incubated in biotin block prior to addition of primary an-
tibody, developed using Envision System horseradish peroxidase (HRP)
(Dako), and counterstained in hematoxylin.
Measurements of NADPH andATP.A commercially available color-
imetric assay kit (catalog number 65349; Abcam) was used to measure
levels of NADPH in fresh liver. ATP/ADP ratios were determined bymea-
suring total ATP with an ATP bioluminescence assay kit, CLS II (catalog
number 11 699 695 001; Roche) before and after conversion of ADP
to ATP.
Measurements of OCR. A Seahorse Bioscience instrument (model
XF24) was used tomeasure the rate of change in dissolved O2 in either: (i)
DMEM buffered to pH 6.8 with piperazine-N,N=-bis(2-ethanesulfonic
acid) (PIPES) for whole hepatocytes or (ii) mitochondrial assay medium
(70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2
mM HEPES, 1 mM EGTA, 0.2% fat-free BSA) for mitochondria isolated
from primary hepatocytes, both in custom 24-well plates. Confluent he-
patocyte cultureswere plated overnight, and the oxygen consumption rate
(OCR) was measured the next day in 2 M oligomycin (port A), 1 M
FCCP (port B), and 1 M antimycin A (port C). The OCR for whole
hepatocytes was then standardized for total protein concentration after
the assay was completed. For isolatedmitochondrial OCRmeasurements,
40g of isolatedmitochondria in 50l were centrifuged to the bottom of
each well of a 24-well plate in the presence of 10 mM pyruvate-malate or
80 M palmitoyl-carnitine–0.5 mM malate and incubated for 10 min
at 37°C. Mitochondrial oxygen consumption was determined in 4 mM
ADP (port A), 2.5 g/ml oligomycin (port B), 4 M carbonyl cyanide p-
(trifluoromethoxy)phenylhydrazon (FCCP) (port C), and 4 M antimy-
cin A (port D). Measurements of O2 concentration were reported in
pmol/min at each time point.
Metabolomic analysis.Unbiased analysis of levels of acyl carnitines
in wild-type and BNip3 null livers, fed and fasted, was performed by
liquid chromatography-mass spectrometry (LC-MS) by the University
of Michigan Nutrition Obesity Research Center (UMNORC), which is
supported by grant DK089503 from the NIH to the University of
Michigan.
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BNip3 is expressed in healthy adult liver. When we examined
expression of both the BNip3 and Nix proteins in adult mouse
tissues by Western blotting (Fig. 1A), we observed high-level ex-
pression of BNip3 in the liver and the heart (Fig. 1A, lanes 1 and 3,
respectively), very low expression in skeletal muscle (Fig. 1A, lane
5), and undetectable BNip3 expression in other tissues examined
(Fig. 1A, lanes 2, 4, and 6 to 9). Nix was expressed at higher levels
in the spleen and testis (Fig. 1A, lanes 4 and 8) than in other tissues
but was not readily detectable in the liver (Fig. 1A, lane 1). Ele-
vated expression of Nix in the spleen is consistent with a role for
Nix in end-stage red blood cells that are present in the red pulp of
adult spleen (55, 57), while high level BNip3 expression in the
heart supports an important role for BNip3 in mitochondrial
function in cardiomyocytes (18). Interestingly, Western blotting
for BNip3 on extracts from liver derived from mice carrying in-
duced deletion of Hif-1, Hif-2, or Arnt/Hif-1 showed that
expression of BNip3 in the liver was not dependent onHif activity,
since it was still expressed in Arnt-deleted liver (Fig. 1B, lane 7).
However, BNip3 was substantially induced in the liver of mice
with induced deletion of Hif-2 (Fig. 1B, lane 5), suggesting that
BNip3 is directly or indirectly repressed by Hif-2 in adult mouse
liver. Robust expression of BNip3 in healthy adult liver is not consis-
tentwith a cell death function forBNip3 in this tissue, and since a role
for BNip3 in normal liver had not been previously reported, we fo-
cused our experiments on defining this activity of BNip3.
FIG 1 (A) Western blot for BNip3 and Nix (and -tubulin as a loading control) on whole-cell extracts from adult mouse tissues (liver, pancreas, heart, spleen,
skeletal muscle, kidney, white adipose tissue [WAT], testis, and brain). (B) Western blot for BNip3 on whole-cell lysates extracted from wild-type, BNip3 null,
Hif-1-deleted,Hif-1 control,Hif-2-deleted,Hif-2 control, Arnt-deleted, orArnt control livers. (C)Western blot for BNip3 onwhole-cell liver extracts from
wild-type and BNip3 null mice that were fasted for 0, 3, 6, or 24 h. (D)Western blot for Nix on whole-cell liver extracts fromwild-type and BNip3 null mice that
were fasted for 0, 6, 12, or 24 h. (E to H) Oil red O staining of frozen liver sections from wild-type (E and G) or BNip3 null (F and H) mice that were either free
fed (E and F) or fasted (G and H) for 24 h.
Glick et al.
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BNip3 is induced in the liver by fasting, while loss of BNip3
results in hepatic steatosis. Given the importance of the liver in
systemic metabolism and responses to nutrient deprivation (38,
46, 54), we examined expression of BNip3 in the liver of fasted
mice. The BNip3 protein wasmarkedly induced above basal levels
by 6 h of fasting,with further induction by 24 hof fasting (Fig. 1C).
In contrast, we did not observe any induction of Nix in the liver of
fasted mice (Fig. 1D). Oil red O staining of liver sections from
free-fedmice showed that BNip3 null liver (Fig. 1F) wasmarkedly
more steatotic than the wild type (Fig. 1E) under normal dietary
conditions. Fasting ofmice promotes lipidmobilization from adi-
pocytes into the liver for oxidation, and overnight fasting of
BNip3 null mice showed further lipid accumulation, with larger,
more numerous lipid vesicles apparent in oil red O-stained liver
sections (Fig. 1H) than was observed for fasted wild-type mice
(Fig. 1G). These results show for the first time that BNip3 protein
levels in the liver are regulated in response to nutrient availability
and that loss of BNip3 results in hepatic steatosis.
Increased lipogenesis and reduced-oxidation of fatty acids
in BNip3 null liver.To investigate the cause of hepatic steatosis in
BNip3 null mice, we examined lipid accumulation, as well as the
rates of both fatty acid oxidation and lipid synthesis, in cultured
primary hepatocytes from wild-type and BNip3 null livers. Stain-
ing of primary hepatocytes from wild-type and BNip3 null liver
with BODIPY (a lipophilic dye) showed that BNip3 null hepato-
cytes stained more strongly for BODIPY (Fig. 2B) than wild-type
hepatocytes (Fig. 2A) when grown overnight in 5 mM glucose (a
physiologically relevant concentration), consistent with greater
lipid accumulation in BNip3 null hepatocytes than for the wild
type. This indicated that BNip3 null hepatocytes in vitro recapit-
ulated the steatotic phenotype observed in vivo (Fig. 1). The
amount of lipid accumulation increased in proportion to the
amount of glucose in the culture medium, with increased
BODIPY staining of BNip3 null hepatocytes at 25 mM glucose
(Fig. 2D) compared to that at 5 mM (Fig. 2B).
Increased lipid accumulation can be attributed to either re-
duced -oxidation of fatty acids or increased lipid synthesis.
When we measured the rate of fatty acid oxidation in cultured
hepatocytes in the presence of 5 mM or 25 mM glucose, we ob-
served a 2- to 3-fold decrease in the -oxidation of fatty acids in
FIG 2 (A to D) Fluorescence microscopy of wild-type and BNip3 null hepatocytes that were stained with the lipophilic dye BODIPY after growth in culture for
24 h in the presence of 5 mM (A and B) or 25 mM (C and D) glucose. (E) Conversion of tritiated palmitate to tritiated water in wild-type and BNip3 null
hepatocytes as a proportion of total protein, in the presence of 5mM glucose, 25mM glucose, 10Metomoxir, or 1mM carnitine (n 6 for each treatment per
genotype). (F) Mass spectrometric analysis of acyl carnitine levels (pmol/mg tissue) in wild-type and BNip3 null livers from free-fed or fasted mice. (G)
Measurement of lipid formed in culture per hour in the presence of 13C-labeled glucose at either a 5 mM (n  13) or 25 mM (n  14) concentration as a
proportion of total protein for both wild-type and BNip3 null hepatocytes. The significance of differences in lipid synthesized between wild-type and Bnip3 null
hepatocytes had a P value of 0.0529 at 5 mM and 0.0373 at 25 mM. (H) Measurement of total cytosolic NADPH as a proportion of total protein (n 6 for each
treatment per genotype). The significance of differences in NADPH levels between wild-type and Bnip3 null hepatocytes had a P value of 0.0714 under free-fed
conditions and 0.0018 under fasted conditions. (I)Western blot analysis for fatty acid synthase (Fasn), acetyl CoA-carboxylase 1/2 (Acc), ATP citrate lyase (Acly),
malic enzyme (Me), and-tubulin onwhole-cell liver extracts fromadultmice that are free fed (lanes 1 and 3) or fasted (lanes 2 and 4). (J)Measurement of serum
nonesterified fatty acids (NEFA) in wild-type and BNip3 null mice before and after 24 h of fasting. Data are represented as means SEM. An unpaired Student
t test was used for evaluation of statistical significance. The asterisk indicates P 0.05.
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BNip3 null liver compared to that in wild-type liver (Fig. 2E). The
efficiency of -oxidation was increased to a greater extent in
BNip3 null hepatocytes than in wild-type hepatocytes by treat-
ment with 1 mM carnitine, which promotes fatty acid uptake by
mitochondria, consistent with reduced fatty acid import into
BNip3 null mitochondria. However, -oxidation remained lower
in BNip3 null hepatocytes than in wild-type ones, arguing that
reduced carnitine availability was not sufficient to explain the full
extent of reduced -oxidation of fatty acids in BNip3 null liver
(Fig. 2E). Consistently, oxidation of fatty acids in BNip3 null
hepatocytes was inhibited to a similar extent as that for the wild
type by treatment with 10 M etomoxir, an inhibitor of carnitine
palmitate transporter 1 (Cpt-1) (Fig. 2E), indicating that while
fatty acid transport into the mitochondria of BNip3 null hepato-
cytes was reduced, it was not completely defective.
Supporting these in vitrofindings,metabolomic analysis of acyl
carnitine content in BNip3 null liver demonstrated a marked re-
duction in mitochondrial content of acyl carnitines under fed
conditions compared to results for liver fromwild-typemice, sug-
gesting reduced import of fatty acids into the mitochondria in
BNip3 null hepatocytes in the fed state (Fig. 2F). In contrast, in-
creased long-chain acyl carnitines (C14 and C16 in particular)
showed increased concentrations in fasted BNip3 null liver com-
pared to those in wild-type liver, consistent with reduced -oxi-
dation of fatty acids in BNip3 null mitochondria under fasting
conditions (Fig. 2F). These results suggest that there is increased
lipid content in BNip3 null liver under fed and fasted conditions,
at least in part due to reduced -oxidation of fatty acids in BNip3
null liver (Fig. 1F).
Increased lipid content could also be explained by an increased
rate of de novo lipid synthesis, and indeed, we observed a 2-fold
increase in the rate of conversion of glucose to lipid in BNip3 null
hepatocytes compared to that for the wild type when grown in 5
mM glucose in vitro (Fig. 2G). Consistent with BODIPY staining,
lipid synthesis increased further in BNip3 null hepatocytes when
the concentration of glucose in the medium was increased to 25
mM, such that now we observed a 3- to 4-fold increase in lipid
synthesis over that for the wild type (Fig. 2G). Lipid synthesis
requires the reducing power of NADPH, generated in the cytosol
through the pentose phosphate pathway or the pyruvate-malate
cycle. Consistent with elevated de novo lipid synthesis in BNip3
null primary hepatocytes in vitro, we detected elevated cytosolic
NADPH levels in vivo in BNip3 null liver from both fed and fasted
mice compared to wild-type levels (Fig. 2H). Furthermore, the
decrease in cytosolic NADPH upon fasting was significantly
smaller in the BNip3 null liver (1.37-fold) than in wild-type liver
(2.45-fold) (Fig. 2H). We also detected elevated expression of the
key enzymes, fatty acid synthase (Fasn), acetyl-coenzymeA (CoA)
carboxylase (Acc), and ATP citrate lyase (Acly), as well as malic
enzyme (Me), in BNip3 null liver from free-fedmice compared to
that in wild-type livers (Fig. 2I, lane 3). Acly, Acc, and Fasn are all
enzymes involved in lipid biosynthesis from cytosolic citrate, and
their upregulation (Fig. 2I, lane 3), alongside increased NADPH
(Fig. 2H), is consistentwith increased lipid synthesis in BNip3 null
liver (Fig. 1F), while increased expression of malic enzyme, which
catalyzes the conversion of malate to pyruvate, likely contributes
to increased NADPH levels (Fig. 2H). Interestingly, increased ex-
pression of Acc in BNip3 null liver under fed conditions (Fig. 2I,
lane 3) may also explain reduced import of fatty acids into the
mitochondria, which contributes to reduced fatty acid oxidation
(Fig. 2E). Increased lipid synthesis and increased levels of lipo-
genic enzymes suggested that loss of BNip3 resulted in the aber-
rant sensing of a high-energy state in the livers of free-fed mice.
Fasting is expected to reduce this high-energy state, and consis-
tently, we observed reduced expression of lipogenic enzymes in
BNip3 null liver from fasted mice (Fig. 2I, lane 4). Thus, BNip3
null hepatocytes are able to receive and respond to the fasting
signal but are nevertheless unable to reverse lipid accumulation,
possibly due to the continued defect in -oxidation of fatty acids
in BNip3 null hepatocytes (Fig. 2E and F). In summary, we ob-
served that loss of BNip3 leads to reduced -oxidation of fatty
acids and increased de novo lipogenesis in cultured hepatocytes
and that this is associated with deregulated transport and oxida-
tion of acyl carnitines, liver steatosis, increased NADPH, and in-
creased expression of lipogenic enzymes in vivo.
Elevated lipid in the liver was not accompanied by a significant
increase in serum free fatty acids (Fig. 2J). Nor was increased liver
steatosis associated with an increase in overall body mass, in-
creased fat-mass-to-lean-mass ratio, or increased food consump-
tion in BNip3 null mice compared to results for age-matched
wild-type littermate control mice, and the respiratory exchange
ratio for thesemice was similar to age- and sex-matchedwild-type
mice under both fed and fasted conditions (data not shown).
These observations suggest that hepatic steatosis in BNip3 null
liver was not due to a systemic problem inmetabolism but reflects
a key function(s) for BNip3 in the liver.
Reduced hepatic glucose output in response to fasting in
BNip3 null mice. Given the observed effects on hepatic lipid me-
tabolism and the inextricable connection between lipid and glu-
cose homeostasis in the liver, we next examined whether loss of
BNip3 also affected glucosemetabolism.Wemeasured serum glu-
cose levels in free fed and fasted mice and observed, as expected, a
decrease in serum glucose in both wild-type and BNip3 null mice
in response to fasting (Fig. 3A). However, the decrease in serum
glucose was greater in fasted BNip3 null mice, suggesting a re-
duced capacity to increase the hepatic glucose output in response
to fasting. The failure of fasted BNip3 nullmice tomaintain serum
glucose levels compared to fasted wild-type mice was not associ-
ated with significant differences in serum insulin levels, which
dropped to comparably low levels in both wild-type and BNip3
null mice in response to fasting (Fig. 3B). When BNip3 null mice
were fasted overnight and then injected with 2.0 g/kg glucose,
serum glucose levels remained at significantly lower levels than
those in wild-type control mice (Fig. 3C). Again, this could not be
attributed to significant differences in serum insulin levels be-
tweenwild-type and BNip3 nullmice during the glucose tolerance
test (Fig. 3D). When BNip3 null mice were injected with 20 U/kg
insulin, serum glucose levels also dropped much more signifi-
cantly than in wild-type mice (Fig. 3E), such that BNip3 null mice
challenged with insulin frequently became severely hypoglycemic
and had to be injected with glucose to restore blood sugar levels.
The increased insulin sensitivity observed in BNip3 null mice was
matched by a marked reduction in the glucagon response. When
stimulated with 20 g/kg glucagon, BNip3 null mice showed a
significantly lower rate of glucose export to the blood than wild-
type mice stimulated with glucagon (Fig. 3F). These results indi-
cate that in addition to defects in lipid metabolism, BNip3 null
liver is defective in its ability to increase glucose output in response
to fasting.
Defective gluconeogenesis in BNip3 null liver. In the imme-
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diate response to fasting, the liver mobilizes glycogen stores to
supply energy to extrahepatic tissues in the form of glucose (38).
The significant reduction in blood glucose levels post-24 h of fast-
ing in BNip3 null mice (Fig. 3A) suggests that the defect in glucose
export is not the result of a failure to store or mobilize glycogen,
since glycogen breakdown is required during only the first few
hours of fasting. Indeed, in situ staining with PAS showed a sig-
nificant reduction in glycogen levels as expected in both the wild-
type and BNip3 null livers following overnight fasting (Fig. 4A to
D), consistent with effective sensing of the fasting signal in BNip3
null liver. Nevertheless, quantification of glycogen levels in the
BNip3 null liver indicated that absolute levels of glycogen were
FIG 3 (A) Measurement of serum glucose in wild-type and BNip3 null mice before and after 24 h of fasting (n 9 for free fed; n 14 for fasted). Differences
between wild-type and BNip3 null mice were insignificant under fed conditions. Under fasted conditions, the differences were significant (P  0.00002). (B)
Measurement of serum insulin in wild-type and BNip3 null mice before and after 24 h of fasting (n 17 for free fed; n 13 for fasted). Differences were not
significant. (C) Glucose tolerance test measuring serum glucose in fasted mice at 15-min intervals after injection with 2 g/kg glucose (n 10 for wild-type; n
14 for BNip3 null). (D)Measurement of serum insulin in wild-type and BNip3 null mice during the GTT shown in panel C. (E) Insulin tolerance test measuring
serum glucose in fasted mice at 15-min intervals after injection with 0.5 U/kg insulin (n 12 for wild type; n 9 for BNip3 null). (F) Glucagon sensitivity test
measuring serum glucose in fasted mice at 15-min intervals after injection with 20 mg/kg glucagon (n  8 for wild type; n  9 for BNip3 null). Data are
represented as means SEM. An unpaired Student t test was used for evaluation of statistical significance. The asterisk indicates P 0.05.
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lower in BNip3 null liver than in the wild type, both in free-fed
mice and in response to overnight fasting (Fig. 4E). Furthermore,
BNip3 null hepatocytes accumulated less glycogen when cultured
overnight in glucose (Fig. 4F). These observations showed that
while BNip3 null liver is able to store glycogen under fed condi-
tions and mobilize it in response to fasting, the overall levels were
reduced under both sets of conditions. Reduced glycogen storage
suggested that glycolysis might be increased. To examine this, we
measured the levels of both glucose-6-phosphate and lactate in
BNip3 null liver extracts compared to wild-type levels, again un-
der fed and fasted conditions. We observed increased levels of
both glucose-6-phosphate (Fig. 4G) and lactate (Fig. 4H) in
BNip3 null liver compared to wild-type levels under fed condi-
tions, consistent with increased glycolysis in BNip3 null liver. The
levels of both of these glycolytic intermediates dropped signifi-
cantly, as expected in response to reduced glucose uptake by the
liver under fasted conditions.
Once liver glycogen stores are depleted within the first few
hours of fasting, the liver generates glucose from pyruvate via
gluconeogenesis (GNG). Lactate and alanine feed pyruvate pro-
duction, and pyruvate is imported into themitochondrion, where
it is preferentially converted into oxaloacetate by pyruvate carbox-
ylase. Oxaloacetate is converted to malate for export back out of
the mitochondrion to the cytosol, where it fuels phosphoenol py-
ruvate (PEP) synthesis and gluconeogenesis (GNG). To deter-
mine if BNip3 null liver was defective for GNG in response to
fasting, as suggested by reduced hepatic glucose output, we per-
formed a pyruvate challenge in which fasted mice were injected
with 1.5 g/kg of sodium pyruvate as an alternative carbon source.
BNip3 null mice showed a markedly reduced ability to utilize py-
ruvate to generate serum glucose in response to fasting compared
to results for wild-type mice (Fig. 5A). Similarly, BNip3 null mice
were unable to efficiently utilize alanine to promote hepatic glu-
cose production (Fig. 5B), as indicated by lower serum glucose in
fasted BNip3 null mice injected with 1.0 g/kg L-alanine.
When we examined expression of key gluconeogenic enzymes,
we observed reduced expression of phosphoenolpyruvate car-
boxykinase (Pepck) and fructose bisphosphatase-1 (Fbp-1) in the
BNip3 null liver compared to that in wild-type liver under fed
conditions (Fig. 5C and D), consistent with an elevated energy
state in BNip3 null liver from fed mice, while expression of the
glycolytic enzyme, liver pyruvate kinase (Pklr), was not affected by
loss of BNip3 (Fig. 5E). However, these genes were properly in-
duced in BNip3 null liver in response to overnight fasting, sug-
gesting that the reduced hepatic glucose output is not due to in-
adequate induction of enzymes required for gluconeogenesis.
Additionally, these data provide further evidence that loss of
BNip3 is not affecting the ability of the liver to receive fasting
signals but rather is limiting its ability to respond.
The observed failure of BNip3 null mice to utilize pyruvate or
alanine to drive GNG combined with the localization of BNip3 to
the outermitochondrial membrane suggested to us that the defect
in hepatic glucose output could be due to defects in shuttlingGNG
precursors through the mitochondrion. To test this, we first com-
pared the abilities of wild-type versus BNip3 null hepatocytes to
utilize either lactate or glycerol to promote glucose output in cul-
ture in the presence or absence of forskolin to mimic the fasting
signal in vitro. Lactate is converted to pyruvate, whichmust first be
shuttled through the mitochondrion in order to fuel GNG, while
glycerol inputs GNG upstream of the mitochondrion to provide
fructose-bisphosphate and can thus drive hepatic glucose output
without the requirement for shuttling intermediates through the
mitochondrion. We showed that lactate was not able to restore
glucose output by BNip3 null hepatocytes to that observed with
wild-type hepatocytes in response to forskolin (Fig. 5F). This is
consistent with our previous observation that BNip3 null liver
FIG 4 (A to D) In situ staining for hepatic glycogen using PAS stain on wild-type (A and C) or BNip3 null (B and D) livers from free-fed (A and B) or fasted (C
andD)mice. (E)Measurement of absolute glycogen in livers fromwild-type andBNip3 nullmice that are free fed or fasted for 24 h (n 7, wild type;n 6, BNip3
null). (F) Rate of glycogen production by wild-type or BNip3 null hepatocytes grown overnight in culture medium containing either 5 mM or 25 mM glucose
(n 10 for all data sets). (G)Measurement of total cytosolic glucose-6-phosphate as a proportion of total protein for wild-type and BNip3 null livers (n 6 for
each data set). (H) LC-MS analysis of lactate levels as a proportion of total protein for wild-type and BNip3 null livers (n  4 for each data set). Data are
represented as means SEM. An unpaired Student t test was used for evaluation of statistical significance. The asterisk indicates P 0.05.
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cannot efficiently utilize either pyruvate or alanine to increase
hepatic glucose production in vivo (Fig. 5A and B). In contrast,
glycerol was used as effectively by BNip3 null hepatocytes as by
wild-type hepatocytes to drive glucose output, which also con-
firms that there is not a defect at the level of glucose export from
the BNip3 null hepatocytes (Fig. 5G). Our results show that there
is a reduced capacity forGNG inBNip3null liver compared to that
for the wild type, which likely explains reduced hepatic glucose
output in BNip3 nullmice under fasting conditions. Furthermore,
these data indicate that this defect occurs at the level of the mito-
chondria, since glycerol but not lactate, alanine, or pyruvate can
restore glucose production to wild-type levels.
Increased mitochondrial mass but reduced mitochondrial
function in BNip3 null liver.Given the reported role of BNip3 in
mitophagy (35, 53, 65, 73) and the importance of functional mi-
tochondria for both lipid metabolism and GNG (11, 38, 40, 47),
FIG 5 (A) Pyruvate challenge test measuring serum glucose in fasted mice at 15-min intervals after injection with 1.5 g/kg pyruvate (n  6, wild type; n  7,
BNip3	/	). (B) Alanine challenge measuring serum glucose in fasted mice at 15-min intervals after injection with 1.0 g/kg alanine (n  3, wild type; n  3,
BNip3	/	). (C to E) Quantitative PCR performed by TaqMan for phosphoenol pyruvate carboxykinase (Pepck), fructose-bisphosphatase-1 (Fbp1), and liver
pyruvate kinase (Pklr). (F) Glucose output in culture bywild-type or BNip3 null hepatocytes as a proportion of total protein using [13C]lactate as a carbon source
(n 6 for each data set). (G) Glucose output in culture by wild-type or BNip3 null hepatocytes as a proportion of total protein using [13C]glycerol as a carbon
source (n 6 for each data set). Data are represented as means SEM. An unpaired Student t test was used for evaluation of statistical significance. The asterisk
indicates P 0.05.
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we postulated that defective mitophagy could explain the ob-
served metabolic defects in the BNip3 null liver. We performed
immunofluorescent staining of primary hepatocyte cultures and
observedmarkedly higher expression of themitochondrial matrix
protein, Hsp60, in BNip3 null hepatocytes (Fig. 6B) than in the
wild type (Fig. 6A). Additionally, measurement of mitochondrial
genome copy number relative to nuclear genome by quantitative
PCR (qPCR) quantified a significant increase in mitochondrial
genome number in BNip3 null liver compared to that in wild-type
liver (Fig. 6C). Finally, Western blotting confirmed a consistent
increase in levels of mitochondrial proteins (Hsp60, Cox-IV, and
cytochrome c) in BNip3 null liver over those in wild-type liver in
both fed and fasted samples (Fig. 6D). These results support the
conclusion that loss of BNip3 leads to an increase in mitochon-
drial mass in BNip3 null liver.
When we measured the respiration of primary hepatocytes in
the presence of 5mM glucose, we observed increased oxygen con-
sumption by BNip3 null hepatocytes compared to that by wild-
type hepatocytes (Fig. 6E, solid lines), asmight be expected in cells
with increased mitochondrial mass. Intriguingly, when we de-
prived hepatocyte cultures of glucose (Fig. 6E, hashed lines), we
observed a dramatic drop-off in respiration by BNip3 null hepa-
tocytes, while wild-type hepatocytes actually increased their res-
piration, consistent with oxidation of fatty acids, a more efficient
energy source than glucose. These observations support the con-
clusion that while BNip3 null hepatocytes can oxidize glucose
more efficiently than wild-type hepatocytes, possibly due to in-
creased mitochondrial mass and increased glycolysis, they are de-
fective at oxidizing alternative carbon sources, such as fatty acids,
consistent with data described for Fig. 2E and 2F, identifying a
defect in -oxidation in BNip3 null hepatocytes.
Increased respiration by BNip3 null hepatocytes was also asso-
ciated with increased generation of superoxide radicals as deter-
mined by in situ staining for dihydroethidine (DHE), an effect that
was exacerbated by overnight fasting (Fig. 6F). Thus, BNip3 loss
promotes increasedmitochondrialmass and increased respiration
but is also associated with elevated production of reactive oxygen
species (ROS).
To determine whether the increased respiration rate of BNip3
null hepatocytes promoted increased ATP production, we mea-
FIG 6 (A and B) Immunofluorescence staining for Hsp60, a mitochondrial matrix protein, on cultured primary hepatocytes isolated from wild-type (A) or
BNip3 null (B) mice. (C) Quantitative PCR performed by TaqMan for mitochondrial genome-encoded Nd-1 or cytochrome b expressed relative to the amount
of nucleus-encoded-globin on total genomicDNAextracted fromwild-type (n 9) andBNip3 null (n 9)mice. (D)Western blot analysis for BNip3, Cox-IV,
cytochrome c, Hsp60, and -tubulin on whole-cell liver extracts from adult mice that are free fed or fasted (24 h). (E) Seahorse XF24 measurement of oxygen
content by whole hepatocytes freshly isolated fromwild-type and BNip3 null liver in the presence or absence of 5 mM glucose. (F) In situ staining of frozen liver
sections with 2 Mdihydroethidine to detect superoxide levels. (G) Measurement of the ATP-to-ADP ratio in fresh liver isolated from wild-type or BNip3 null
mice that were either free fed or fasted for 24 h. (H)Western blot analysis for the -subunit of AMP-regulated kinase (AMPK), phospho-AMP-regulated kinase
(phospho-Thr172), Raptor and phospho-Raptor (Ser792), and -tubulin on whole-cell liver extracts from adult mice that are free fed (lanes 1 and 3) or fasted
(lanes 2 and 4). Data are represented as means SEM. An unpaired Student t test was used for evaluation of statistical significance. The asterisk indicates P
0.05.
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sured ATP and ADP levels in lysates from wild-type and BNip3
null liver collected from free-fed and fasted mice and quantified a
significant increase in theATP/ADP ratio in BNip3 null liver com-
pared to that for the wild type under free-fed conditions (Fig. 6G).
High ATP levels and low AMP levels reduce the activity of AMP-
regulated kinase (AMPK) (23), and consistent with observed in-
creases in ATP levels, we observed reduced expression of phos-
pho-Thr172-AMPK in liver from free-fed BNip3 null mice
compared to wild-type expression (Fig. 6H, lane 3), although
overall levels of AMPK subunit  were not changed, indicating
reduced activity of AMPK in BNip3 null liver from free-fed mice.
Consistently, levels of phospho-Raptor (Ser 792), an established
AMPK substrate (21), were also reduced in BNip3 null liver from
fed mice (Fig. 6H, lane 3). The observed reduction in AMPK ac-
tivity in BNip3 null liver may contribute to the observed changes
in expression of lipid synthesis enzymes, such as Fasn, Acc, Acly,
and Me, that are indirectly suppressed by AMPK activity (37).
Overall, our findings that loss of BNip3 leads to increased mito-
chondrial mass and increased respiration and ATP generation but
reduced AMPK activity are consistent with the aberrant sensing of
a high-energy state in BNip3 null liver, which in turn results in
increased lipogenesis and reduced -oxidation (Fig. 2), as well as
reduced expression of gluconeogenic enzymes under fed condi-
tions (Fig. 5).
While defects in mitophagy increase mitochondrial mass, they
also can lead to the accumulation of defective mitochondria (27,
29, 65, 70), and thus we postulated that the inability of BNip3 null
mitochondria to oxidize fatty acids properly (Fig. 2) or to effi-
ciently shuttle GNG intermediates to the cytosol (Fig. 5) reflected
defective mitochondrial function. Fluorescent staining of live
hepatocytes for MitoTracker green (taken up by functional and
nonfunctional mitochondria alike) showed increased dye uptake
by BNip3 hepatocytes (Fig. 7B) compared to wild-type results
(Fig. 7A), confirming that BNip3 null hepatocytes have increased
numbers of mitochondria. However, when these primary hepato-
cyte cultures were stained for TMRE (a potentiometric dye taken
up only by functional mitochondria), we observed a marked re-
duction in TMRE staining in BNip3 null hepatocytes (Fig. 7D)
compared to wild-type levels (Fig. 7C), which was most apparent
in themerged green-red image (compare Fig. 7F to Fig. 7E). These
results indicate that excess mitochondria were accumulating in
BNip3 null hepatocytes with a partial loss of membrane potential.
When we examined ultrastructural features of liver mitochondria
by transmission electron microscopy (TEM) (Fig. 7G to L), we
again observed increased numbers of mitochondria in the BNip3
null livers (Fig. 7H) compared to wild-type livers (Fig. 7G), but
these excess mitochondria were abnormally small and more elec-
tron dense (perhaps reflecting increased long-chain fatty acids)
and frequently showed a loss of outermembrane integrity (Fig. 7L,
black arrows). TEMalso detected increased lipid vesicle content in
BNip3 null liver (Fig. 7J, red arrow), consistent with oil red O
staining (Fig. 1F). These results support a role for BNip3 in main-
tainingmitochondrial integrity in adultmouse liver. The observed
mitochondrial abnormalities were not associated with an obvious
defect in global autophagy, since we observed similar levels of
LC3B processing by Western blotting in BNip3 null liver com-
pared to wild-type results (Fig. 8), in contrast to that reported in
autophagy-defective Atg7-deficient liver (31). In addition, we did
FIG 7 (A to F) Fluorescence microscopy of primary wild-type (A, C, and E) or BNip3 null (B, D, and F) hepatocytes stained with MitoTracker green (A and B)
to stain all mitochondria and TMRE (red) as a measure of intact mitochondrial membrane potential (C and D), with the merged images of MitoTracker green
andTMRE shown below (E and F). (G to L) Transmission electronmicroscopy of thin sections from adultmouse liver fromwild-type (G, I, andK) or BNip3 null
(H, J, and L) mice at increasing magnification. Scale bars are shown in the bottom left of each panel. (M and N) Oxygen consumption by isolated mitochondria
fromwild-type (red) or BNip3null (blue) hepatocytes in the presence of 4mMADP, 2.5g/ml oligomycin, 4MFCCP, or 4Mantimycin using either pyruvate
(M) or palmitate (N) as a substrate. Experiments were performed in quadruplicate using the Seahorse Bioscience XF24 machine.
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not observe an accumulation of p62 in BNip3 null liver (Fig. 8C),
as would be expected if there was a more general defect in au-
tophagy (30, 31). Interestingly, immunohistochemical staining
revealed differences in the zonal patterning of both LC3B-II and
p62 in wild-type liver, with increased perivenous staining and re-
duced periportal staining in wild-type liver in response to 24 h of
fasting (Fig. 8B and D). In the BNip3 null liver, this increase in
punctate LC3B-II in perivenous regions of the liver was more
marked, confirming that the response to fasting was intact and
suggesting that defective mitochondria may actually increase lev-
els of autophagy in regions of the liver, possibly due to the ob-
served insufficiencies in -oxidation. While overall p62 did not
accumulate in BNip3 null liver, we observed localized increases in
p62 in individual hepatocytes (Fig. 8D), suggesting that some cells
in the BNip3 liver were defective for autophagy, possibly due to
the marked accumulation of lipid.
Although BNip3 null hepatocytes isolated from 3-month-old
male mice showed an overall increase in respiration when cul-
tured in 5 mM glucose (Fig. 6E), this could be attributed to the
overall increase inmitochondrialmass in BNip3 nullmice (Fig. 6B
to D). When we performed respiration studies with isolated mi-
tochondria using pyruvate as a substrate for oxidation, we ob-
served that mitochondria from BNip3 null liver consumed less
oxygen in the presence of ADP (added after 10min) than an equal
number of wild-type control mitochondria (Fig. 7M). This effect
was particularly marked when the ATPase proton pump was in-
hibited at 20 min with oligomycin (Fig. 7M). The failure to main-
tain oxygen consumption when oligomycin was added indicates
that healthymitochondria isolated fromBNip3 null liver aremore
dependent on oxidative phosphorylation for ATP generation than
wild-typemitochondria. This effect was particularly strikingwhen
palmitate rather than pyruvate was used as a substrate (Fig. 7N),
consistent with BNip3 null mitochondria being defective for fatty
acid oxidation, as determined above in other assays (Fig. 2E and
6E). These results show that loss of BNip3 leads to increased mi-
tochondrial mass with a concomitant increase in mitochondrial
dysfunction.
BNip3 null mice develop steatohepatitis. In addition to in-
creased lipid accumulation (Fig. 1 and 2) and elevated reactive
oxygen species accumulation (Fig. 6H), histological analysis re-
vealed increased leukocyte infiltration into the liver of BNip3 null
mice (Fig. 9B, black arrows) compared to findings for wild-type
liver (Fig. 9A). These inflammatory infiltrates included neutro-
phils that stained positively for myeloperoxidase (Fig. 9C) and B
lymphocytes that stained positively for B220 (Fig. 9D). The prox-
imity of leukocyte infiltration (Fig. 9F, black arrow) to regions of
the BNip3 liver that stained positive by TUNEL assay (Fig. 9F, red
arrows) suggested that the increased inflammation was linked to
cell death of hepatocytes. Indeed, PAS staining identified PAS-
positive hepatocyte remnants (Fig. 9G andH,white arrows) inside
resident tissue phagocytes (dark-staining nuclei) under both free-
FIG 8 (A) Western blot for LC3B on whole-cell liver extracts from wild-type and BNip3 null mice that were fasted for 0, 3, or 24 h. (B) Immunohistochemical
staining for the autophagymarker, processed LC3B-II, on wild-type and BNip3 null liver before and after fasting. (C)Western blot analysis of p62/sequestrin on
whole-cell liver extracts from wild-type and BNip3 null mice that were fasted for 0 or 24 h. (D) Immunohistochemical staining for p62/sequestrin on wild-type
and BNip3 null liver before and after fasting.
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fed and fasted conditions, indicating that loss of BNip3 leads to
steatohepatitis.
In summary, we have identified a key role for BNip3 in the liver
to limit lipogenesis and promote fatty acid oxidation in the fed
state and promote gluconeogenesis in the fasted state. Specifi-
cally, we propose that by limiting mitochondrial mass and pro-
moting mitochondrial integrity, BNip3 is required in the liver
to regulate energy homeostasis, with a loss of BNip3 leading to
increased mitochondrial mass, elevated ATP, and reduced
AMPK activity, resulting in the aberrant sensing of a high-
energy state in the liver. However, increased mitochondrial
mass was offset by reduced mitochondrial function and was
associated with increased reactive oxygen species generation,
inflammation, and steatohepatitis. This work demonstrates
how a loss of BNip3 results in altered metabolic states and
reduced mitochondrial integrity and highlights the importance
of examining mitophagy in diseases linked to irregular lipid
and glucose maintenance.
DISCUSSION
The liver integrates systemic control of glucose output to the
blood in response to nutrient availability (38). Imbalances be-
tween anabolic processes in the liver, such as lipid synthesis under
fed conditions and catabolic processes, such as -oxidation of
fatty acids and gluconeogenesis in response to fasting, have been
implicated in liver diseases, such as nonalcoholic fatty liver disease
(NAFLD) and nonalcoholic steatohepatitis (NASH), as well as
hepatic insulin resistance and type 2 diabetes (5, 38, 43, 47, 61).
Given that the mitochondrion is the major site of fatty acid oxi-
dation, Krebs cycle, and oxidative phosphorylation in the cell,
there is considerable interest in explaining how alteredmitochon-
drial function contributes to the pathobiology of metabolic dis-
eases (2, 11, 36, 40, 47, 48, 61). Todate, suchmitochondrial defects
include abnormalities in fatty acid oxidation (12, 33, 63, 72), mi-
tochondrial biogenesis (66, 69), and oxidative phosphorylation
(2, 10, 50). Our data demonstrate for the first time a specific role
for mitophagy in maintaining liver homeostasis.
Increasedmitochondrialmass in BNip3 null liver is offset by
reducedmitochondrial function.Mitophagy is a key cellular pro-
cess used to eliminate dysfunctional mitochondria (62, 70), and
indeed, De Duve’s observation that glucagon induced mitochon-
drial autophagy in the liver was the basis of his Nobel prize
awarded in 1974 (13, 14). We have identified a novel role for
BNip3 in regulating the balance between lipid synthesis and fatty
acid oxidation in the liver and in promoting gluconeogenesis in
response to fasting. Consistent with this role, BNip3 is induced in
the liver in response to fasting, and loss of BNip3 increased insulin
sensitivity while reducing glucagon responsiveness. We suggest
that this phenotype is consistent with the canonical function of
BNip3 as a regulator of mitochondrial fragmentation and mi-
tophagy (35, 53, 65, 73), given that increased mitochondrial mass
is observed in BNip3 null liver as expected if mitochondrial turn-
over is reduced (Fig. 10A). However, increased mitochondrial
mass was offset by reduced mitochondrial function in terms of
structural integrity, membrane polarization, and oxygen con-
sumption (Fig. 10B).
These two consequences of BNip3 loss undoubtedly oppose
each other in terms of effect on ATP production at the mitochon-
dria, with increasedmitochondrial mass promoting increased ox-
ygen consumption and ATP generation (Fig. 10B) while reduced
mitochondrial function leads to reduced -oxidation, mitochon-
drial overload, reduced oxygen consumption, reduced ATP pro-
duction, and ROS production (Fig. 10B and C). The net effect on
ATP levels will therefore likely be the balance of these two oppos-
ing effects of BNip3 loss—in other words, determined by how
many of the surplus mitochondria are functional. Our results
show that the ATP/ADP ratio is increased in BNip3 null liver from
free-fed mice at 3 months of age compared to results for age-
matched wild-type mice, suggesting that the positive effects of
increased mitochondrial mass on ATP production initially pre-
dominate over the negative effect of reduced mitochondrial func-
tion (Fig. 10C). However, we predict that this balance will shift
with increasing age of the mice, and ongoing work is aimed at
addressing this intriguing issue.
FIG 9 (A and B) Hematoxylin-and-eosin staining of wild-type (A) or BNip3 null (B) liver (black arrows indicate infiltrating leukocytes). (C) Immunohisto-
chemical staining for the neutrophil-specificmarkermyeloperoxidase onBNip3null liver. (D) Immunohistochemical staining for the B cell-specificmarker B220
on BNip3 null liver. (E and F) TUNEL staining of wild-type (E) or BNip3 null (F) liver. Black arrows indicate infiltrating leukocytes. Red arrows indicate regions
staining positive for TUNEL. (G andH) PAS staining of liver from free-fed and 24-h-fasted BNip3 null livers atmagnification
1,000, highlighting regions of cell
death in which PAS-positive hepatocellular cytoplasm is detected in resident phagocytes (white arrows).
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Aberrant sensing of a high-energy state is associated with
increased mitochondrial mass, increased respiration, and ele-
vated ATP production. Our work shows that elevated ATP pro-
duction resulting from increased mitochondrial mass in BNip3
null liver leads to the aberrant sensing of a high-energy state, as
confirmed by reduced AMPK activity (Fig. 6H), increased expres-
sion of lipogenic enzymes, and increased lipid synthesis (Fig. 2).
Reduced AMPK activity blocks -oxidation of fatty acids and in-
creases lipogenesis (24), both features of altered metabolism ob-
served in BNip3 null liver. Of note, the lipogenic enzymes that we
show to be induced in BNip3 null liver (Fasn, Acc, Acly, and Me)
are all transcriptionally regulated by SREBP1 (11), which is in turn
inhibited by AMPK-dependent phosphorylation (37). Increased
Acc may also explain reduced transport of fatty acids into the
mitochondria, reduced -oxidation of fatty acids under fed con-
ditions (Fig. 2) modulated through Acc2 activity at the outer mi-
tochondrial membrane, and increased lipogenesis through in-
creased AccI activity in the cytosol. In summary, our work
indicates that reducedmitophagy leads to steatosis in the liver and
predicts that activating AMPK should limit lipogenesis in the
BNip3 null liver; however, AMPK activation would not necessar-
ily rescue other effects of mitochondrial dysfunction on the met-
abolic phenotype observed in BNip3 null mice, such as reduced
-oxidation of fatty acids or reduced gluconeogenesis.
Defective -oxidation of fatty acids in BNip3 null hepato-
cytes. Our work here has identified for the first time a role for
BNip3 in regulating mitochondrial mass and integrity in the liver
that has significance for liver metabolism and disease. Loss of mi-
tochondrial functionmay be the result of increasedROSproduced
at the mitochondria that damages lipid membranes or protein
function, which then results in defective -oxidation and gluco-
neogenesis. Conversely, the defect in -oxidation may be damag-
ing mitochondria as long-chain fatty acids accumulate in the ma-
trix, resulting in mitochondrial overload, and this may be the
major causative factor that limits gluconeogenesis and feeds back
to further inhibit fatty acid oxidation. For example, intramito-
chondrial accumulation of acyl-CoAs induced by high-fat feeding
of mice resulted in hepatic insulin resistance that corresponded
directly with the degree of mitochondrial dysfunction, including
reduced respiration and reduced fatty acid oxidation (33, 47).
This cause-and-effect dilemma posed by our data raises the
possibility that BNip3 plays additional, more direct roles in me-
tabolism over and above its function in mitophagy. For example,
BNip3 has been reported to interact directly with acetyl-CoA acyl
transferase 2 (Acaa2), an enzyme involved in fatty acid oxidation
in the mitochondrial matrix (6). However, BNip3 localizes to the
outer mitochondrial membrane, making an interaction with a
matrix protein such as Acaa2 unlikely. In contrast, Acc2 does co-
localize with BNip3 to the outer mitochondrial membrane and is
negatively regulated by AMPK (23, 58). Together with our data
showing upregulation of Acc2 in BNip3 null liver and the key role
of Acc2 downstream of AMPK activity in inhibiting -oxidation
through inhibition of Cpt-1 activity, this suggests that perhaps
Acc2 is negatively regulated by BNip3 at the outer mitochondrial
membrane. Given that loss of Acc2 in mice protects against obe-
sity and diabetes induced by a high-fat diet by increasing uptake of
fatty acid by mitochondria and promoting -oxidation of fatty
acids (1), it may therefore be useful to examine how overexpres-
sion (as opposed to loss) of BNip3 affects hepatic insulin resis-
tance and other aspects of metabolic disease.
FIG 10 (A) Loss of BNip3 leads to increased mitochondrial mass in the liver due to a defect in turnover of mitochondria at the autophagosome (mitophagy).
Increased mitochondrial mass leads to increased oxygen consumption, increased ATP production, and the aberrant sensing of a high-energy state, leading to
increased lipogenesis. (B) Failure to turn over mitochondria leads to increased mitochondrial mass but the accumulation of defective mitochondria that are
unable to carry out -oxidation of fatty acids properly and accumulation of long-chain fatty acids in the mitochondria, further exacerbating mitochondrial
dysfunction, resulting in a loss of membrane potential and ROS production. (C) The effect of BNip3 on liver metabolism is therefore likely to be determined by
the balance between levels ofmitochondria and the proportion that are functional for-oxidation of fatty acids, oxidative phosphorylation, and gluconeogenesis.
Over time, in the absence of increased biogenesis or cell proliferation, the balance will move toward increased mitochondrial dysfunction, which can lead to cell
death, compensating proliferation, inflammation, and disease.
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BNip3 as a downstreammediator of Hif effects on liver me-
tabolism. BNip3 is a HIF target gene, and regional hypoxia plays
an important role in gene regulation and zonation of metabolic
activities in the liver (26). We observed increased BNip3 protein
levels in liver that is deleted for Hif-2 (Fig. 1B), suggesting that
Hif-2may repress BNip3 expression in liver. Intriguingly, liver-
specific deletion of the Von Hippel-Lindau (Vhl) tumor suppres-
sor inmice resulted in hepatic steatosis and hypoglycemia (51), an
effect that was specifically dependent on Hif-2, such that knock-
out of Hif-2 but not Hif-1 rescued the observed steatosis and
hypoglycemia. Thus, it will be interesting to determine the extent
to which rescue of the phenotype in Vhl-deleted liver by Hif-2
deletion is dependent on derepression of BNip3. It will also be
interesting to determine the mechanism by which BNip3 is in-
duced by fasting signals and how these signals are integrated into
liver homeostatic responses to changing systemic nutrient supply.
In summary, our work has revealed a novel connection be-
tween defective mitophagy and regulation of lipid metabolism in
the liver that has ramifications for the etiology of diseases linked to
hepatic steatosis, such as NASH and type 2 diabetes. This work
identifies BNip3 as a potential target for therapeutic intervention
if the mechanisms regulating its levels and activity in liver can be
elucidated.
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